P701-0183 Screening compound: N-[(2-chlorophenyl)methyl]-2-{4-[4-(thiophen-2-yl)-1,3-thiazol-2-yl]-1H-imidazol-1-yl}acetamide

P701-0183 Screening compound: N-[(2-chlorophenyl)methyl]-2-{4-[4-(thiophen-2-yl)-1,3-thiazol-2-yl]-1H-imidazol-1-yl}acetamide
P701-0183 Screening compound: N-[(2-chlorophenyl)methyl]-2-{4-[4-(thiophen-2-yl)-1,3-thiazol-2-yl]-1H-imidazol-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P701-0183
N-[(2-chlorophenyl)methyl]-2-{4-[4-(thiophen-2-yl)-1,3-thiazol-2-yl]-1H-imidazol-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P701-0183

Molecular Formula

C19H15ClN4OS2 (C19 H15 ClN4 OS2)

Compound Name

N-[(2-chlorophenyl)methyl]-2-{4-[4-(thiophen-2-yl)-1,3-thiazol-2-yl]-1H-imidazol-1-yl}acetamide

IUPAC name

N-[(2-chlorophenyl)methyl]-2-{4-[4-(thiophen-2-yl)-13-thiazol-2-yl]-1H-imidazol-1-yl}acetamide

SMILES

O=C(Cn1cnc(-c2nc(-c3cccs3)cs2)c1)NCc(cccc1)c1Cl

InChI

InChI=1S/C19H15ClN4OS2/c20-14-5-2-1-4-13(14)8-21-18(25)10-24-9-15(22-12-24)19-23-16(11-27-19)17-6-3-7-26-17/h1-7,9,11-12H,8,10H2,(H,21,25)

InChI Key

FQBNRPHLCINEKD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27612599

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.94

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.583

Distribution Coefficient, logD

4.583

Water Solubility, LogSw

-4.56

Polar Surface Area

47.254

Acid Dissociation Constant (pKa)

13.05

Base Dissociation Constant (pKb)

3.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.50

P701-0183 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P701-0183 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P701-0183?
Check Price and Availability of P701-0183, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P701-0183 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P701-0183
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P701-0183
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P701-0183 available by request